173 related articles for article (PubMed ID: 36678206)
1. Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial.
Best KP; Sullivan TR; Gunaratne AW; Gould JF; Gibson RA; Collins CT; Makrides M; Green TJ
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678206
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trial.
Gunaratne AW; Makrides M; Collins CT; Gibson RA; McPhee AJ; Sullivan TR; Gould JF; Green TJ; Doyle LW; Davis PG; French NP; Colditz PB; Simmer K; Morris SA; Best KP
Am J Clin Nutr; 2019 Jun; 109(6):1600-1610. PubMed ID: 31070712
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.
Collins CT; Gibson RA; Anderson PJ; McPhee AJ; Sullivan TR; Gould JF; Ryan P; Doyle LW; Davis PG; McMichael JE; French NP; Colditz PB; Simmer K; Morris SA; Makrides M
BMJ Open; 2015 Mar; 5(3):e007314. PubMed ID: 25787990
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Collins CT; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Smithers LG; Willson K; Ryan P
JAMA; 2009 Jan; 301(2):175-82. PubMed ID: 19141765
[TBL] [Abstract][Full Text] [Related]
5. Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial.
Gould JF; Makrides M; Sullivan TR; Anderson PJ; Gibson RA; Best KP; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong J; Davis PG; Sharp M; Simmer K; Collins CT
BMJ Open; 2021 Feb; 11(2):e041597. PubMed ID: 33550243
[TBL] [Abstract][Full Text] [Related]
6. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized, controlled trial.
Groh-Wargo S; Jacobs J; Auestad N; O'Connor DL; Moore JJ; Lerner E
Pediatr Res; 2005 May; 57(5 Pt 1):712-8. PubMed ID: 15718356
[TBL] [Abstract][Full Text] [Related]
7. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
[TBL] [Abstract][Full Text] [Related]
8. Subgroup analyses of a randomized trial of DHA supplementation for infants born preterm with assessments of cognitive development up to 7-years of age: What happens in infants born <29 weeks' gestation?
Gould JF; Bednarz JM; Sullivan TR; McPhee AJ; Gibson RA; Makrides M
Prostaglandins Leukot Essent Fatty Acids; 2023 Dec; 198-199():102593. PubMed ID: 37979339
[TBL] [Abstract][Full Text] [Related]
9. Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years.
Gould JF; Makrides M; Gibson RA; Sullivan TR; McPhee AJ; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Bednarz JM; Davis PG; Simmer K; Doyle LW; Collins CT
N Engl J Med; 2022 Oct; 387(17):1579-1588. PubMed ID: 36300974
[TBL] [Abstract][Full Text] [Related]
10. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial.
O'Connor DL; Hall R; Adamkin D; Auestad N; Castillo M; Connor WE; Connor SL; Fitzgerald K; Groh-Wargo S; Hartmann EE; Jacobs J; Janowsky J; Lucas A; Margeson D; Mena P; Neuringer M; Nesin M; Singer L; Stephenson T; Szabo J; Zemon V;
Pediatrics; 2001 Aug; 108(2):359-71. PubMed ID: 11483801
[TBL] [Abstract][Full Text] [Related]
11. Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Best KP; Collins CT
BMJ Open; 2021 May; 11(5):e044740. PubMed ID: 33952546
[TBL] [Abstract][Full Text] [Related]
12. Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm.
Sullivan TR; Gould JF; Bednarz JM; McPhee AJ; Gibson R; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Davis PG; Simmer K; Collins CT; Doyle LW; Makrides M
JAMA Netw Open; 2023 Jun; 6(6):e2317870. PubMed ID: 37294565
[TBL] [Abstract][Full Text] [Related]
13. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
[TBL] [Abstract][Full Text] [Related]
14. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.
Auestad N; Scott DT; Janowsky JS; Jacobsen C; Carroll RE; Montalto MB; Halter R; Qiu W; Jacobs JR; Connor WE; Connor SL; Taylor JA; Neuringer M; Fitzgerald KM; Hall RT
Pediatrics; 2003 Sep; 112(3 Pt 1):e177-83. PubMed ID: 12949309
[TBL] [Abstract][Full Text] [Related]
15. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
[TBL] [Abstract][Full Text] [Related]
16. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
17. Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis.
Marc I; Boutin A; Pronovost E; Perez Herrera NM; Guillot M; Bergeron F; Moore L; Sullivan TR; Lavoie PM; Makrides M
JAMA Netw Open; 2023 Mar; 6(3):e233934. PubMed ID: 36943265
[TBL] [Abstract][Full Text] [Related]
18. Effect of arachidonic and docosahexaenoic acid supplementation on quality of growth in preterm infants: A secondary analysis of a randomized controlled trial.
Rossholt ME; Bratlie M; Wendel K; Aas MF; Gunnarsdottir G; Fugelseth D; Pripp AH; Domellöf M; Størdal K; Stiris T; Moltu SJ
Clin Nutr; 2023 Dec; 42(12):2311-2319. PubMed ID: 37856920
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic and Arachidonic Acid Supplementation of Toddlers Born Preterm Does Not Affect Short-Term Growth or Adiposity.
Ingol TT; Li R; Boone KM; Rausch J; Klebanoff MA; Turner AN; Yeates KO; Nelin MA; Sheppard KW; Keim SA
J Nutr; 2019 Dec; 149(12):2182-2190. PubMed ID: 31187863
[TBL] [Abstract][Full Text] [Related]
20. The effect of maternal DHA supplementation on body fat mass in children at 7 years: follow-up of the DOMInO randomized controlled trial.
Wood K; Mantzioris E; Lingwood B; Couper J; Makrides M; Gibson RA; Muhlhausler BS
Prostaglandins Leukot Essent Fatty Acids; 2018 Dec; 139():49-54. PubMed ID: 29032859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
